GH Research

GHRS

GH Research is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Velichka Valcheva, with a market cap of $1.9B.

Market cap

$1.92B+121%

We’re still putting together GH Research’s detailed financials. Its latest earnings are below. You’ll find its full filings on SEC EDGAR, or explore the companies we cover.

Ask us to move GH Research up the queue, and we’ll analyze its filings next.

Earnings

Q1 2026 report

May 14, 2026

EPS-$0.31Miss by $0.04

Read the full report

Next report

Aug 6, 2026 (In 1 week)

EPS estimate-$0.31

Profile

CountryIreland

Listed2021

Employees49.0

CEOVelichka Valcheva

SectorHealthcare

IndustryBiotechnology

Websiteghres.com

FilingsSEC EDGAR